Veterinary Medicines

Damtix 2000 mg/400 mg spot-on solution for dogs over 25 kg

Authorised
  • Permethrin (40:60)
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Damtix 2000 mg/400 mg spot-on solution for dogs over 25 kg
DAMTIX 2000 mg/400 mg soluzione spot-on per cani oltre 25 kg
Active substance:
  • Permethrin (40:60)
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Permethrin (40:60)
    2000.00
    milligram(s)
    /
    1.00
    Pipette
  • Imidacloprid
    400.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 10 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 6 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 4 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 3 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 1 pipette

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105613
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0663/004
Concerned member states:
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Portugal
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 6/07/2025
Download
Italian (PDF)
Published on: 31/05/2024
Download

Summary of Product Characteristics

English (PDF)
Published on: 6/07/2025
Download